Get the Stockscreener App
4.49
0.45%
0.02
Cargo Therapeutics Inc stock is traded at $4.49, with a volume of 673.48K.
It is up +0.45% in the last 24 hours and up +7.16% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
See More
Previous Close:
$4.47
Open:
$4.47
24h Volume:
673.48K
Relative Volume:
0.50
Market Cap:
$207.03M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-1.2522
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
-0.66%
1M Performance:
+7.16%
6M Performance:
+24.72%
1Y Performance:
-73.11%
1-Day Range:
$4.45
$4.495
1-Week Range:
$4.445
$4.53
52-Week Range:
$3.00
$25.45
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
4.49 | 207.93M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-30-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-30-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Jan-30-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-30-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-30-25 | Downgrade | Truist | Buy → Hold |
| Jan-30-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
Why is CARGO Therapeutics Inc. stock attracting strong analyst attentionFinancial News Tracker With High Returns - jammulinksnews.com
Tools to assess CARGO Therapeutics Inc.’s risk profileFree Community Strategy With High Win Rate - Newser
Is CARGO Therapeutics Inc. forming a reversal patternOversold Stock Bounce Playbook Generator - Newser
What institutional investors are buying CARGO Therapeutics Inc. stockLow Risk Recommendation With High Returns - jammulinksnews.com
What are the technical indicators suggesting about CARGO Therapeutics Inc.Best Dividend Entry Points For Every Investor - jammulinksnews.com
When is CARGO Therapeutics Inc. stock expected to show significant growthFree Stock Recommendation From AI Tools - jammulinksnews.com
Should I hold or sell CARGO Therapeutics Inc. stock in 2025Beginner Investor Insights That Work - jammulinksnews.com
What Fibonacci levels say about CARGO Therapeutics Inc. rebound3-Day Market Movement Forecast Analysis - Newser
Chart based exit strategy for CARGO Therapeutics Inc.Free Daily Stock Market Swing Alerts - Newser
Full technical analysis of CARGO Therapeutics Inc. stockEntry Zone Watchlist With Momentum Focus - Newser
How to recover losses in CARGO Therapeutics Inc. stockFree Reliable Investment Entry Point Signals - Newser
Is CARGO Therapeutics Inc. still worth holding after the dipTechnical Long-Term Outlook and Recap Guide - Newser
Can machine learning forecast CARGO Therapeutics Inc. recoveryTechnical Analysis of Growth Stock Opportunities - Newser
Using flow based indicators on CARGO Therapeutics Inc.2-Day Signal Watch with Forecast Outcome - Newser
Price action breakdown for CARGO Therapeutics Inc.Smart Trade Forecast Based on Neural Logic - Newser
11 Best New Penny Stocks to Buy Right Now - Insider Monkey
What to do if you’re stuck in CARGO Therapeutics Inc.Free Risk Adjusted Technical Entry Plan - Newser
CARGO Therapeutics Inc. stock chart pattern explainedFree Weekly Stock Watch With Growth Focus - Newser
Key External Factors That Drive CARGO Therapeutics Inc. Stock Price MovementsWeekly Stock Picks with Trend Confidence - Newser
Predicting CARGO Therapeutics Inc. trend using moving averagesWeekly Movement Forecast With Chart Signals - Newser
Jefferies Raises Price Target for Cargo Therapeutics (CRGX), Keeps Hold Rating - Insider Monkey
Is CARGO Therapeutics Inc. a Top Dividend Stock to Watch in 2025Free Fast Gaining Stock Screener Report - Newser
Sectors Driving Future Growth for CARGO Therapeutics Inc. StockEntry Opportunity Screener with Confirmation - Newser
Is CARGO Therapeutics Inc. stock a good hedge against inflationBreakout Screener With Alert Based Timing - Newser
How Interest Rate Changes Impact CARGO Therapeutics Inc. Stock PerformanceReal Stock Picks With Setup Verification - Newser
Why CARGO Therapeutics Inc. stock attracts strong analyst attentionFree Weekly Watchlist of High Movers - Newser
Key metrics from CARGO Therapeutics Inc.’s quarterly dataBear Market Safe Zone Technical Analysis - Newser
What data driven models say about CARGO Therapeutics Inc.’s futureFree Low Risk Equity Screener With Results - Newser
How CARGO Therapeutics Inc. stock performs during market volatilityHigh Yield Watchlist with Filtered Picks - Newser
Published on: 2025-07-29 05:06:49 - metal.it
CARGO Therapeutics Inc. Ranks High in Smart Money TrackerReal-Time Trade Insights Spark Market Reactions - metal.it
How strong is CARGO Therapeutics Inc. company’s balance sheetRemarkable growth - jammulinksnews.com
What are CARGO Therapeutics Inc. company’s key revenue driversBuild a diversified portfolio for stability - jammulinksnews.com
What are analysts’ price targets for CARGO Therapeutics Inc. in the next 12 monthsBreakneck growth rates - jammulinksnews.com
How many analysts rate CARGO Therapeutics Inc. as a “Buy”Capitalize on market shifts before others do - jammulinksnews.com
What is the dividend policy of CARGO Therapeutics Inc. stockMaximize portfolio value with smart investment plans - jammulinksnews.com
What is the risk reward ratio of investing in CARGO Therapeutics Inc. stockMaximize your returns with smart trade entries - jammulinksnews.com
What are the latest earnings results for CARGO Therapeutics Inc.Achieve rapid wealth accumulation through smart investing - jammulinksnews.com
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cargo Therapeutics Inc Stock (CRGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Radhakrishnan Anup | See Remarks |
May 14 '25 |
Sale |
3.84 |
27,404 |
105,272 |
122,413 |
| Radhakrishnan Anup | See Remarks |
Apr 03 '25 |
Sale |
4.00 |
1,629 |
6,522 |
77,317 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Option Exercise |
5.03 |
7,166 |
36,045 |
111,071 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Option Exercise |
5.03 |
2,975 |
14,964 |
106,880 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Sale |
25.09 |
7,166 |
179,775 |
103,905 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Sale |
25.03 |
2,975 |
74,457 |
103,905 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Option Exercise |
5.03 |
1,600 |
8,048 |
8,046 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Sale |
25.28 |
1,600 |
40,452 |
6,446 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):